| Metric | შპს SIAPHARM | სს საქართველოს ნავთობისა და გაზის კორპორაცია |
|---|---|---|
| Growth | ||
| Revenue | ₾3.9m₾4.5m | ₾997.2m₾873.7m |
| Revenue growth | -15.0% | 14.1% |
| Profitability | ||
| EBITDA | ₾379k₾12k | ₾206.7m₾200.2m |
| EBITDA margin | 9.8%0.3% | 20.7%22.9% |
| Net profit | ₾157k-₾63k | ₾3.2m₾120.2m |
| Net margin | 4.1%-1.4% | 0.3%13.8% |
| Balance sheet | ||
| Total assets | ₾1.7m₾1.8m | ₾1.84bn₾1.88bn |
| Total equity | ₾368k₾212k | ₾907.3m₾1.05bn |
| ROE | 42.6%-30.0% | 0.4%11.4% |